The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery

PHASE3RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Fuchs' Endothelial DystrophyCataract
Interventions
DRUG

Ripasudil

"Glanatec Ophthalmic Solution 0.4% W/V with ripasudil hydrochloride hydrate as active ingredient is currently being used by patients with ocular hypertension or open-angle glaucoma.~Inhibition of Rho kinase to facilitate aqueous outflow from the conventional outflow pathway via the trabecular meshwork and Schlemm's canal has been suggested as the IOP-lowering mechanism of action by ripasudil."

OTHER

Placebo

Saline eye drops

Trial Locations (1)

168751

RECRUITING

Singapore National Eye Centre, Singapore

All Listed Sponsors
lead

Singapore Eye Research Institute

OTHER